Literature DB >> 8942248

Oral premedications in paediatric day surgery.

B C Ong1, A S Ng, S L Chew.   

Abstract

The degree of sedation in 191 day-stay children after oral premedication were compared. One hundred and forty-six were 1-5 years old (Group 1) and were randomised to receive either chloral 40 mg/kg, midazolam 0.2 mg/kg, promethazine 1 mg/kg, trimeprazine 3 mg/kg or placebo. Forty-five were 5-12 years old and were randomised to receive either trimeprazine 3 mg/kg, midazolam 0.2 mg/kg or placebo (Group 2). The children were assessed using four categories: asleep or drowsy, awake but calm, crying or anxious and oversedated or obstructed airway. They were assessed on leaving the ward, at separation from the parents, at induction, in the recovery room and one and two hours after returning to the ward. In Group 1, it was found that chloral and trimeprazine gave the best degree of sedation but the sedative effect of trimeprazine lasted longer into the post operative period. In Group 2, it was found that the children did not require deep sedation and the anxiolysis obtained with midazolam was adequate.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8942248

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  3 in total

1.  Paediatric sedation for imaging is safe and effective in a district general hospital.

Authors:  Mark A Bailey; Arun Saraswatula; Gemma Dale; Laura Softley
Journal:  Br J Radiol       Date:  2016-03-09       Impact factor: 3.039

2.  Factors affecting efficacy of oral trimeprazine sedation for dental procedures in children: A retrospective study.

Authors:  Lanre L Bello
Journal:  Saudi Dent J       Date:  2011-02-03

3.  Efficacy of Chloral Hydrate and Promethazine for Sedation during Electroencephalography in Children; a Randomised Clinical Trial.

Authors:  Fallah Razieh; Jalili Sharam; Golestan Motahhareh; Akhavan Karbasi Sedighah; Jarahzadeh Mohammad-Hosein
Journal:  Iran J Pediatr       Date:  2013-02       Impact factor: 0.364

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.